← All trials
NCT00391469
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2007
- Primary completion
- May 31, 2013
- Completion date
- Aug 31, 2013
- First posted
- Oct 24, 2006
- Last posted
- Dec 2, 2014
- Enrollment
- 1359
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of WashingtonLead sponsor
- Medic One FoundationCollaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of WashingtonOverall official - principal investigator
- University of WashingtonReponsible party - principal investigator
- University of WashingtonStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.